Please use this identifier to cite or link to this item:
|Title:||Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway|
|Author:||López Isac, Elena|
Campillo Davo, Diana
Bossini Castillo, Lara
Guerra, Sandra G.
Simeón Aznar, Carmen Pilar
Ortego Centeno, Norberto
García de la Peña, Paloma
Distler, Jörg H.V.
Voskuyl, Alexandre E.
Vries-Bouwstra, Jeska de
Denton, Christopher P.
Radstake, Timothy R.D.J.
Mayes, Maureen D.
Spanish Scleroderma Group
Espinosa Garriga, Gerard
|Publisher:||BMJ Publishing Group|
|Abstract:||OBJECTIVES: TYK2 is a common genetic risk factor for several autoimmune diseases. This gene encodes a protein kinase involved in interleukin 12 (IL-12) pathway, which is a well-known player in the pathogenesis of systemic sclerosis (SSc). Therefore, we aimed to assess the possible role of this locus in SSc. METHODS: This study comprised a total of 7103 patients with SSc and 12 220 healthy controls of European ancestry from Spain, USA, Germany, the Netherlands, Italy and the UK. Four TYK2 single-nucleotide polymorphisms (V362F (rs2304256), P1104A (rs34536443), I684S (rs12720356) and A928V (rs35018800)) were selected for follow-up based on the results of an Immunochip screening phase of the locus. Association and dependence analyses were performed by the means of logistic regression and conditional logistic regression. Meta-analyses were performed using the inverse variance method. RESULTS: Genome-wide significance level was reached for TYK2 V362F common variant in our pooled analysis (p=3.08×10(-13), OR=0.83), while the association of P1104A, A928V and I684S rare and low-frequency missense variants remained significant with nominal signals (p=2.28×10(-3), OR=0.80; p=1.27×10(-3), OR=0.59; p=2.63×10(-5), OR=0.83, respectively). Interestingly, dependence and allelic combination analyses showed that the strong association observed for V362F with SSc, corresponded to a synthetic association dependent on the effect of the three previously mentioned TYK2 missense variants. CONCLUSIONS: We report for the first time the association of TYK2 with SSc and reinforce the relevance of the IL-12 pathway in SSc pathophysiology.|
|Note:||Reproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2015-208154|
|It is part of:||Annals of the Rheumatic Diseases, 2015, vol. 75, num. 8, p. 1521-1526|
|Appears in Collections:||Articles publicats en revistes (Medicina)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.